Immediate Impact
58 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
The immunostimulatory nature of mRNA lipid nanoparticles
2024 Standout
Works of Judith Bluvstein being referenced
Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
2021
Lorcaserin therapy for severe epilepsy of childhood onset
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Judith Bluvstein | 175 | 47 | 61 | 89 | 83 | 10 | 269 | |
| Ilan Linder | 131 | 60 | 52 | 109 | 178 | 11 | 313 | |
| Jules C. Beal | 176 | 72 | 53 | 80 | 129 | 15 | 325 | |
| E. E. Patterson | 185 | 137 | 32 | 90 | 31 | 8 | 335 | |
| Richard Tang‐Wai | 106 | 63 | 30 | 50 | 83 | 15 | 274 | |
| Jussi Mäkinen | 211 | 74 | 36 | 57 | 19 | 15 | 298 | |
| Pedro Beleza | 175 | 64 | 95 | 99 | 11 | 16 | 279 | |
| Carlotta Stipa | 130 | 38 | 60 | 54 | 9 | 20 | 254 | |
| Nicole Dierschke | 187 | 18 | 95 | 51 | 22 | 7 | 313 | |
| Walid Fazeli | 41 | 34 | 8 | 83 | 49 | 16 | 285 | |
| Chloe Verducci | 171 | 85 | 35 | 87 | 96 | 9 | 254 |
All Works
Login with ORCID to disown or claim papers
Loading papers...